African Journal of
Biochemistry Research

  • Abbreviation: Afr. J. Biochem. Res.
  • Language: English
  • ISSN: 1996-0778
  • DOI: 10.5897/AJBR
  • Start Year: 2007
  • Published Articles: 418

Full Length Research Paper

Prevalence of dyslipidemia in a Burkinabe military population

Raoul Karfo
  • Raoul Karfo
  • Laboratoire d’analyse biomédicale de la clinique du Centre Médicale du Camp General Aboubacar Sangoulé Lamizana, Ouagadougou, Burkina Faso.
  • Google Scholar
Fabrice Mohamed Kangambega
  • Fabrice Mohamed Kangambega
  • Laboratoire d’analyse biomédicale de la clinique du Centre Médicale du Camp General Aboubacar Sangoulé Lamizana, Ouagadougou, Burkina Faso.
  • Google Scholar
Elie Kabre
  • Elie Kabre
  • Laboratoire de biochimie, Unité de Formation et de Recherche en Sciences de la Santé, Université Joseph Ki-Zerbo de Ouagadougou, Burkina Faso.
  • Google Scholar
Ouedraogo Paulette
  • Ouedraogo Paulette
  • Laboratoire National de Santé Publique, Ouagadougou, Burkina Faso.
  • Google Scholar
Zakaria Nacro
  • Zakaria Nacro
  • Laboratoire d’analyse biomédicale de la clinique du Centre Médicale du Camp General Aboubacar Sangoulé Lamizana, Ouagadougou, Burkina Faso.
  • Google Scholar
Zakaria Sanogo
  • Zakaria Sanogo
  • Laboratoire d’analyse biomédicale de la clinique du Centre Médicale du Camp General Aboubacar Sangoulé Lamizana, Ouagadougou, Burkina Faso.
  • Google Scholar
Adama Dao
  • Adama Dao
  • Laboratoire d’analyse biomédicale de la clinique du Centre Médicale du Camp General Aboubacar Sangoulé Lamizana, Ouagadougou, Burkina Faso.
  • Google Scholar
Jean Sakandé
  • Jean Sakandé
  • Laboratoire de biochimie, Unité de Formation et de Recherche en Sciences de la Santé, Université Joseph Ki-Zerbo de Ouagadougou, Burkina Faso.
  • Google Scholar
Lassane Sangaré
  • Lassane Sangaré
  • Laboratoire d’analyse biomédicale de la clinique du Centre Médicale du Camp General Aboubacar Sangoulé Lamizana, Ouagadougou, Burkina Faso.
  • Google Scholar


  •  Received: 04 November 2019
  •  Accepted: 08 January 2020
  •  Published: 31 January 2020

References

Adébayo A, Albert CD, Angelo CA, Jules G, Moutawakilou G, Armand W, Léopold C, Colette A, Djimon MZ, François D (2016). Profil lipidique des personnes vivant avec le VIH sous antirétroviral suivis au Centre Hospitalier Universitaire Ouémé-Plateaux (CHU-O/P) de Porto-Novo, Bénin. International Journal of Biological and Chemical Sciences 10(5):2175-2182.
Crossref

 

Agboola-Abu CF, Ohwovoriole AE, Akinlade KS (2000). The effect of glycaemic control on the prevalence and pattern of dyslipidemia in Nigerian patients with newly diagnosed non-insulin dependent diabetes mellitus. West African Journal of Medicine 19(1):1-5.

 
 

Balaka A, Djibril MA, Tchamdja T, Djagadou KA, Mossi E, Nemi KD (2017). Cardiopathies ischémiques et dyslipidémies en milieu professionnel postal au Togo. Revue Africaine de Médecine Interne 4(1):7-9.

 
 

Baragou S, Djibril M, Atta B, Damorou F, Pio M, Balogou A (2012). Prevalence of cardiovascular risk factors in an urban area of Togo: a WHO STEPS-wise approach in Lome, Togo. Africa Cardiovascular Journal of Africa 23(6):309-312.
Crossref

 
 

Dominique D, Abdou SM, Fatou AD, Modou J, Arame N, Adama K, Alassane D, Meissa T (2014). Lipid profile frequency and the prevalence of dyslipidemia from biochemical tests at Saint Louis University Hospital in Senegal. Pan African Medical Journal 17:75.
Crossref

 
 

Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M (2008). Prevalence of dyslipidemias and associated risk factors among Turkish adults: Trabzon Lipid Study. Endocrine 34(13):36- 51.
Crossref

 
 

Expert Panel on Detection (2001). Evaluation, and Treatment of High Blood Cholesterol in Adults.Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). The Journal of the American Medical Association 285(19):2486-97.
Crossref

 
 

Fatou C, Fatou DA, Alassane D, Abdou SM, Arame N, Abdourahmane S, Souleymane T, Dominique D, Gaston NS, Niama DS, Méissa T (2016). Prévalence des dyslipidémies au laboratoire de biochimie du CHU Aristide le Dantec de Dakar, Sénégal. The Pan African Medical Journal 25:67.
Crossref

 
 

Ferrieres J, Ruidavets JB, Perret B, Dallongeville J, Arveiler D, Bingham A, Amouyel P, Haas B, Ducimetiere P (2005). Prévalence des dyslipidémies dans un échantillon représentatif de la population française. Archives des Maladies du Coeur et des Vaisseaux 98(2):127-32.

 
 

Gao Y, Zhong XN, Yang YH, Tian KC (2012). Plasma lipid level and incidence of dyslipidemia in workers of Chongqing enterprises and institutions. Zhonghua Xin Xue Guan Bing Za Zhi 40(5):432-435.

 
 

Guira O, Nagalo A, Tiéno H, Zoungrana L, Bognounou R , Tondé A , Traoré R, Sakandé J, Drabo J Y (2018). LDL cholestérol chez le diabétique de type 2 nouvellement diagnostiqué au Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou (Burkina Faso). Revue Africaine de Médecine Interne 5(2):37-42.

 
 

Hajar R (2017). Risk factors for coronary artery disease: historical perspectives. Heart Views 18(3):109-114.
Crossref

 
 

Julian PH, José RB, Carine R, Jean D, Guy DB, Eliseo G, Joep P, David H, Karin MH, Claudio B (2017). Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study. BioMed Central Cardiovascular Disorders 17:160.
Crossref

 
 

Khader YS, Batieha A, El-Khateeb M, Al Omari M, Ajlouni K (2010). Prevalence of dyslipidemia and its associated factors among Jordanian adults. Journal of Clinical Lipidology 4(1):53-58.
Crossref

 
 

Micah FB, Nkum BC (2012). Lipid disorders in hospital attendants in Kumasi, Ghana. Ghana Medical Journal 46(1):14-21.

 
 

Oghagbon EK, Okesina AB (2006). The pattern of some risk factors for cardiovascular disease in untreated Nigerian hypertensive patients. West African Journal of Medicine 25(3):190-194.
Crossref

 
 

Pessinaba S, Mbaye A, Yabéta GAD, Harouna H et al. Pessinaba S, Mbaye A , Yabéta GAD, Harouna H, Sib AE, Kane AD, Bodian M, Ndiaye MB, Mbaye-Ndour M, Niang K, Diagne-Sow D, Diack B, Kane M, Diao M, Mathieu JBS, Kane A (2013). Enquête de prévalence des facteurs de risque cardiovasculaire en population générale à Saint-Louis (Sénégal). Annales de Cardiologie Angeiologie 62(4):253-258.
Crossref

 
 

Robert H, Nelson MD (2013). Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Primary Care: Clinics in Office Practice 40(1):195-211.
Crossref

 
 

Scheidt-Nave C, Du Y, Knopf H, Schienkiewitz A, Ziese T, Nowossadeck E, Gößwald A, Busch MA (2013). Prevalence of dyslipidemia among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS 1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(5-6):661-667.
Crossref

 
 

Tiahou G, Deret K, Monde A. Agniwo Camara-Cissé M, Djohan Y, Djessou P, Sess D (2010). Fréquence des bilans lipidiques et prévalence des dyslipidémies au laboratoire de biochimie du chu de Cocody. Journal Pharmaceutical and Biological Sciences 11(2):60-65.

 
 

Tian J, Chen H, Jia F, Yang G, Li S, Li K, Zhang L, Wu J, Liu D (2015). Trends in the levels of serum lipids and lipoproteins and the prevalence of dyslipidemia in adults with newly diagnosed type 2 diabetes in the Southwest Chinese Han Population during 2003-2012. International Journal of Endocrinology pp. 1-7.
Crossref

 
 

Tóth PP, Potter D, Ming EE (2012). Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey. Journal of Clinical Lipidology 6(4):325-330.
Crossref

 
 

Yahia-Berrouiguet A, Benyoucef M, Meguenni K, Faivre B, Brouri M (2009). Enquête sur la prévalence des facteurs de risque de maladies cardiovasculaires à Tlemcen (Algérie). Diabetes and Metabolism 35(1):42-43.
Crossref